Glucose Deprivation-induced Cytotoxicity and Alterations in Mitogen-activated Protein Kinase Activation Are Mediated by Oxidative Stress in Multidrug-resistant Human Breast Carcinoma Cells*
- Yong J. Lee‡§,
- Sandra S. Galoforo‡,
- Christine M. Berns‡,
- Jenn C. Chen¶,
- Bruce H. Davis¶,
- Julia E. Sim‖,
- Peter M. Corry‡ and
- Douglas R. Spitz‖
- From the ‡Department of Radiation Oncology and the¶Department of Clinical Pathology, William Beaumont Hospital, Royal Oak, Michigan 48073 and the ‖Section of Cancer Biology, Radiation Oncology Center, Washington University School of Medicine, St. Louis, Missouri 63108
Abstract
We previously observed that glucose deprivation induces cell death in multidrug-resistant human breast carcinoma cells (MCF-7/ADR). As a follow up we wished to test the hypothesis that metabolic oxidative stress was the causative process or at least the link between causative processes behind the cytotoxicity. In the studies described here, we demonstrate that mitogen-activated protein kinase (MAPK) was activated within 3 min of being in glucose-free medium and remained activated for 3 h. Glucose deprivation for 2–4 h also caused oxidative stress as evidenced by a 3-fold greater steady state concentration of oxidized glutathione and a 3-fold increase in pro-oxidant production. Glucose and glutamate treatment rapidly suppressed MAPK activation and rescued cells from cytotoxicity. Glutamate and the peroxide scavenger, pyruvate, rescued the cells from cell killing as well as suppressed pro-oxidant production. In addition the thiol antioxidant, N-acetyl-l-cysteine, rescued cells from glucose deprivation-induced cytotoxicity and suppressed MAPK activation. These results suggest that glucose deprivation-induced cytotoxicity and alterations in MAPK signal transduction are mediated by oxidative stress in MCF-7/ADR. These results also support the speculation that a common mechanism of glucose deprivation-induced cytotoxicity in mammalian cells may involve metabolic oxidative stress.
Footnotes
-
↵* This work was supported by NCI Grants CA48000 and CA44550 and NHLBI Grant HL51469 from the National Institutes of Health and the William Beaumont Hospital Research Institute Grant 97–06.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵§ To whom correspondence should be addressed: Dept. of Radiation Oncology, Research Laboratories, William Beaumont Hospital, 3601 W. Thirteen Mile Rd., Royal Oak, MI 48073. Tel.: 248-551-2568; Fax: 248-551-2443.
-
↵1 The abbreviations used are: MAPK, mitogen-activated protein kinase; ERK, extracellular regulated protein kinases; NAC, N-acetyl-l-cysteine; PAGE, polyacrylamide gel electrophoresis.
-
- Received September 11, 1997.
- Revision received November 26, 1997.
- The American Society for Biochemistry and Molecular Biology, Inc.











